BioMed Research International / 2014 / Article / Tab 2 / Review Article
Biomarkers as Predictors of Recurrence following Curative Resection for Pancreatic Ductal Adenocarcinoma: A Review Table 2 Summary of original articles on biomarkers for predicting PDA recurrence following curative resection.
Author Year Biomarker Cut-off level (U/mL) Follow-up (months) Recurrence (%) Survival Disease-free (months) Overall median (months) Overall 5-year (%) Sugiura et al. [7 ] 2012 CA 19-9 100 NR 73.3 11 25 27.2 Kang et al. [8 ] 2007 Adjusted CA 19-9 50 12 69 22.6 39.6 (mean) 16.4 Tian et al. [9 ]
1992 CA 19-9 37 NR 54.5 NR 8.7a (mean) NR Hata et al. [10 ] 2012 CA 19-9 37 NR 70 NR 16 20.3 Hernandez et al. [11 ]
2009 CA 19-9 Velocity NR 41 80.2 7 12 NR Kelly et al. [12 ] 2009 CTC RT-PCR positive 10.3 NR NR NR NR Mataki et al. [13 ] 2004 CTCs RT-PCR positive 49 35b NR NR NR Garcea et al. [14 ] 2011 NLR 5 NR NR 27 35 NR Oshima et al. [15 ] 2013 P16/CDKN2A TP53 SMAD4/DPC4 Presence/loss Normal/abnormal Presence/loss NR 78.1 NR 22.1 17.5 Nagai et al. [16 ] 2009 Metastin Present/absent 18.5 62.3 NR NR NR Foo et al. [17 ] 2013 PTEN Retained/loss 40.7 88.2c 12.1 ± 1.9 25.2 ± 3.0 NR Bachet et al. [18 ] 2012 CXCR4 Low/high 54 65.2 14.5 30 NR Niedergethmann et al. [19 ] 2004 CTSB Grades 0 + 1 versus grades 2 + 3 36 58.6 NR 16 NR Niedergethmann et al. [20 ]
2002 VEGF Grades 0 + 1 versus grades 2 + 3 31 58.6 NR 16 NR Jamieson et al. [21 ] 2012 miR-21 miR-34a High Low 23.9 23.9 77 77 NR NR 16.5 13.4 NR NR
Among cases with failed CA 19-9 normalization.
Among patients with pancreatic cancer.
Among cases with loss of PTEN. U/mL, unit/milliliter; NR, not reported; CA 19-9, carbohydrate antigen 19-9; CTCs, circulating tumor cells; RT-PCR, reverse transcriptase polymerase chain reaction; NLR, neutrophil-lymphocyte ratio; PTEN, phosphatase and tensin; CXCR4, CX chemokine receptor 4; CTSB, Cathepsin B.